코미팜
8,290KRWMarket close of 10/27 (Tue)
Up +0.12%+10KRWMarket close of 10/27 (Tue)
Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)8,680KRWUp +4.70%
Preliminary · replaced once official KRX data for the same date is published
- Open
- 8,250
- High
- 8,440
- Low
- 8,100
- Day range
- Day range low 8,100 high 8,440, open 8,250, close 8,290, previous close 8,280
- Volume
- 23×10K shares
- 1.9B KRW 0.56× the 20-session average
Market close of 10/27 (Tue)
Where it sits in the 1-year range
42%1-year close range 5,890 to 11,550 won, 42% up from the low
42% of the way up from the lowest close in 1 year (252 sessions) · -28.2% from the high
Loading
Free · no sign-inSource from 2021-05-17
Data dateMost recent closing data10/27 (Tue)
Market close data of 2026-10-27Points to check
- Recent filingsnot verifiedCould not read filing data, so not verified
- Daily moveusual range+0.12%+0.12%, 0.0× the usual (20-session average ±2.95%)That day +0.12% · usual ±2.95% · large-move threshold ±5.9%
- Trading valueusual range0.6×1.9B KRW, 0.6× the 20-session average0.56× the 20-session average · check threshold 3×
The other 2 are within the usual range
- EarningsOperating income, 8 quarters
- Foreign & institutional-300.00 million KRWusual range
See the full check report
Same sector · 제약
Down -2.22%· 88 of 168 stocks up, preferred shares excluded · trading value 553.0B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +0.6% | Down -5.37% | 124.5B KRW |
| 셀트리온 | Close over the last 20 sessions +6.3% | Down -0.74% | 82.4B KRW |
| 지투지바이오 | Close over the last 20 sessions +22.2% | Down -13.38% | 46.9B KRW |
| 한미약품 | Close over the last 20 sessions -32.6% | Down -0.57% | 25.5B KRW |
| 에스티팜 | Close over the last 20 sessions -11.9% | Down -9.15% | 21.4B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 19 days
- Next data 10/29 (Thu) after 08:50
Related news
Loading
Tables, financials, investor flows and filing history are in the Detailed view.
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.